Tech Company Financing Transactions
AXONIS Therapeutics Funding Round
AXONIS Therapeutics, based in Cambridge, secured $5 million from Alexandria Venture Investments, BoxOne Ventures and Christopher & Dana Reeve Foundation.
Transaction Overview
Company Name
Announced On
7/15/2021
Transaction Type
Venture Equity
Amount
$5,000,000
Round
Undisclosed
Investors
Proceeds Purpose
Proceeds purposes were not disclosed.
Company Information
Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
700 Main St.
Cambridge, MA 02139
USA
Cambridge, MA 02139
USA
Phone
Undisclosed
Website
Email Address
Overview
AXONIS Therapeutics is advancing breakthrough drug discovery to develop groundbreaking therapies for spinal cord injury, and other currently incurable neurological disorders, making a real difference for patients, their families, and global healthcare system.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Joanna Stanicka
Chief Scientific Officer
Shane Hegarty
Browse more venture capital transactions:
Prev: 7/15/2021: M1 Finance venture capital transaction
Next: 7/16/2021: LearnWorlds venture capital transaction
Share this article
Where The Data Comes From
We do our best to report on every notable VC transaction. VC investment data records reported here are derived from company press releases and news coverage. The information comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs